KR101125225B1 - A composition for skin wrinkle improvement comprising extracts or fractions of Eremochloa ophiuroides as an active ingredient - Google Patents
A composition for skin wrinkle improvement comprising extracts or fractions of Eremochloa ophiuroides as an active ingredient Download PDFInfo
- Publication number
- KR101125225B1 KR101125225B1 KR1020090111510A KR20090111510A KR101125225B1 KR 101125225 B1 KR101125225 B1 KR 101125225B1 KR 1020090111510 A KR1020090111510 A KR 1020090111510A KR 20090111510 A KR20090111510 A KR 20090111510A KR 101125225 B1 KR101125225 B1 KR 101125225B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- fractions
- active
- methanol
- fraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000284 extract Substances 0.000 title claims abstract description 86
- 230000037303 wrinkles Effects 0.000 title claims abstract description 40
- 239000000203 mixture Substances 0.000 title claims abstract description 27
- 230000006872 improvement Effects 0.000 title claims abstract description 24
- 239000004480 active ingredient Substances 0.000 title claims abstract description 23
- 241000025852 Eremochloa ophiuroides Species 0.000 title abstract description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 96
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 239000002537 cosmetic Substances 0.000 claims description 19
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 14
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- 238000004440 column chromatography Methods 0.000 claims description 7
- 239000002038 ethyl acetate fraction Substances 0.000 claims description 7
- 150000001298 alcohols Chemical class 0.000 claims description 5
- 239000012046 mixed solvent Substances 0.000 claims 2
- 102000016387 Pancreatic elastase Human genes 0.000 abstract description 10
- 108010067372 Pancreatic elastase Proteins 0.000 abstract description 10
- -1 fractions thereof Substances 0.000 abstract description 8
- 230000002401 inhibitory effect Effects 0.000 abstract description 4
- 102000016942 Elastin Human genes 0.000 abstract description 3
- 108010014258 Elastin Proteins 0.000 abstract description 3
- 229920002549 elastin Polymers 0.000 abstract description 3
- 241001433310 Eremochloa Species 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 39
- 241000258920 Chilopoda Species 0.000 description 32
- 239000011521 glass Substances 0.000 description 29
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 22
- 244000025254 Cannabis sativa Species 0.000 description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 19
- 238000002360 preparation method Methods 0.000 description 18
- 239000000401 methanolic extract Substances 0.000 description 17
- 230000002849 elastaseinhibitory effect Effects 0.000 description 16
- 238000004519 manufacturing process Methods 0.000 description 16
- 230000000694 effects Effects 0.000 description 12
- 238000000605 extraction Methods 0.000 description 10
- 240000008042 Zea mays Species 0.000 description 9
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 9
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 9
- 235000005822 corn Nutrition 0.000 description 9
- 239000000469 ethanolic extract Substances 0.000 description 9
- FKIYLTVJPDLUDL-SLNHTJRHSA-N Isorhoifolin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C=C3C(C(C=C(O3)C=3C=CC(O)=CC=3)=O)=C(O)C=2)O1 FKIYLTVJPDLUDL-SLNHTJRHSA-N 0.000 description 8
- FKIYLTVJPDLUDL-FLPYCHHVSA-N Isorhoifolin Natural products C[C@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3cc(O)c4C(=O)C=C(Oc4c3)c5ccc(O)cc5)[C@H](O)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H](O)[C@@H]1O FKIYLTVJPDLUDL-FLPYCHHVSA-N 0.000 description 8
- 235000013305 food Nutrition 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 230000002829 reductive effect Effects 0.000 description 8
- 229930000044 secondary metabolite Natural products 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 238000011160 research Methods 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 6
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- 239000003960 organic solvent Substances 0.000 description 6
- 239000008194 pharmaceutical composition Substances 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- FKIYLTVJPDLUDL-ZWUNSDNISA-N Apigenin 7-O-rutinoside Natural products O(C[C@@H]1[C@@H](O)[C@H](O)[C@H](O)[C@H](Oc2cc(O)c3C(=O)C=C(c4ccc(O)cc4)Oc3c2)O1)[C@H]1[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 FKIYLTVJPDLUDL-ZWUNSDNISA-N 0.000 description 5
- 230000001153 anti-wrinkle effect Effects 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 235000013402 health food Nutrition 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 229920001592 potato starch Polymers 0.000 description 5
- 239000003755 preservative agent Substances 0.000 description 5
- 239000003826 tablet Substances 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 4
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 235000013365 dairy product Nutrition 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 239000000945 filler Substances 0.000 description 4
- 235000015203 fruit juice Nutrition 0.000 description 4
- 238000007654 immersion Methods 0.000 description 4
- 235000012149 noodles Nutrition 0.000 description 4
- 235000014347 soups Nutrition 0.000 description 4
- 239000003381 stabilizer Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 239000006188 syrup Substances 0.000 description 4
- 235000020357 syrup Nutrition 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- ODBRNZZJSYPIDI-UHFFFAOYSA-N 3',4',5,7-tetrahydroxy-6-C-glucopyranosylflavone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=C(OC(=CC2=O)C=3C=C(O)C(O)=CC=3)C2=C1O ODBRNZZJSYPIDI-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 3
- PLAPMLGJVGLZOV-UHFFFAOYSA-N Epi-orientin Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=C(O)C2=C1OC(C=1C=C(O)C(O)=CC=1)=CC2=O PLAPMLGJVGLZOV-UHFFFAOYSA-N 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- WJJFWGUVMIUWGG-UHFFFAOYSA-N Stereolensin Natural products OC1C(O)C(O)C(CO)OC1OC1=C(O)C=C(OC(=CC2=O)C=3C=C(O)C(O)=CC=3)C2=C1O WJJFWGUVMIUWGG-UHFFFAOYSA-N 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 235000015278 beef Nutrition 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 235000019439 ethyl acetate Nutrition 0.000 description 3
- 235000013355 food flavoring agent Nutrition 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- ODBRNZZJSYPIDI-VJXVFPJBSA-N isoorientin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(OC(=CC2=O)C=3C=C(O)C(O)=CC=3)C2=C1O ODBRNZZJSYPIDI-VJXVFPJBSA-N 0.000 description 3
- UYJGIAWJIRZBNU-UHFFFAOYSA-N isoorientin Natural products OCC1OC(C(O)C(O)C1O)c2cc(O)c(O)c3C(=O)C=C(Oc23)c4ccc(O)c(O)c4 UYJGIAWJIRZBNU-UHFFFAOYSA-N 0.000 description 3
- IUYFTHKQEWZTHY-LQQQXCKLSA-N isoorientin 2''-O-rhamnoside Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)OC1O[C@H]1[C@H](C=2C(=C3C(=O)C=C(OC3=CC=2O)C=2C=C(O)C(O)=CC=2)O)O[C@H](CO)[C@@H](O)[C@@H]1O IUYFTHKQEWZTHY-LQQQXCKLSA-N 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- 239000002032 methanolic fraction Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 229960003471 retinol Drugs 0.000 description 3
- 235000020944 retinol Nutrition 0.000 description 3
- 239000011607 retinol Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- DRLZZQRQMWQRLZ-UHFFFAOYSA-N 6-C-Arabinosyl-8-C-glucosyl apigenin Natural products OCC1OC(C(O)C1O)c2c(O)c(C3OC(CO)C(O)C(O)C3O)c4OC(=CC(=O)c4c2O)c5ccc(O)cc5 DRLZZQRQMWQRLZ-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- OVMFOVNOXASTPA-UHFFFAOYSA-N Neoisoschaftoside Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C(C2C(C(O)C(O)CO2)O)=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O OVMFOVNOXASTPA-UHFFFAOYSA-N 0.000 description 2
- RBVAFYCFAFADAG-UHFFFAOYSA-N Orientin Natural products OCC1OC(C(O)c2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccc(O)c(O)c4)C(O)C1O RBVAFYCFAFADAG-UHFFFAOYSA-N 0.000 description 2
- 235000004347 Perilla Nutrition 0.000 description 2
- 244000124853 Perilla frutescens Species 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 229960003767 alanine Drugs 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 235000007215 black sesame Nutrition 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- 235000021329 brown rice Nutrition 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000006837 decompression Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- KCIDZIIHRGYJAE-YGFYJFDDSA-L dipotassium;[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate Chemical compound [K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O KCIDZIIHRGYJAE-YGFYJFDDSA-L 0.000 description 2
- 239000007884 disintegrant Substances 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 239000003974 emollient agent Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 239000004088 foaming agent Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000003349 gelling agent Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 235000015243 ice cream Nutrition 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- OVMFOVNOXASTPA-ZUGZFPASSA-N iso-schaftoside Natural products O=C1c2c(O)c([C@H]3[C@@H](O)[C@@H](O)[C@@H](O)CO3)c(O)c([C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)c2OC(c2ccc(O)cc2)=C1 OVMFOVNOXASTPA-ZUGZFPASSA-N 0.000 description 2
- OVMFOVNOXASTPA-VYUBKLCTSA-N isoschaftoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C([C@H]2[C@@H]([C@@H](O)[C@@H](O)CO2)O)=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O OVMFOVNOXASTPA-VYUBKLCTSA-N 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 2
- 229930019673 naringin Natural products 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 2
- 229940108325 retinyl palmitate Drugs 0.000 description 2
- 235000019172 retinyl palmitate Nutrition 0.000 description 2
- 239000011769 retinyl palmitate Substances 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- 235000019204 saccharin Nutrition 0.000 description 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 2
- 229940081974 saccharin Drugs 0.000 description 2
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 2
- MMDUKUSNQNWVET-UHFFFAOYSA-N schaftozide Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C(C2C(C(O)C(O)CO2)O)=C(OC(=CC2=O)C=3C=CC(O)=CC=3)C2=C1O MMDUKUSNQNWVET-UHFFFAOYSA-N 0.000 description 2
- 239000003352 sequestering agent Substances 0.000 description 2
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 229960004793 sucrose Drugs 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- 235000015192 vegetable juice Nutrition 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 240000001879 Digitalis lutea Species 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 241000380130 Ehrharta erecta Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920002701 Polyoxyl 40 Stearate Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229930002945 all-trans-retinaldehyde Natural products 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- XJKITIOIYQCXQR-SCUNHAKFSA-N all-trans-retinyl linoleate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C XJKITIOIYQCXQR-SCUNHAKFSA-N 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000015197 apple juice Nutrition 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000010633 broth Nutrition 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 239000007963 capsule composition Substances 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 235000015190 carrot juice Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 235000012495 crackers Nutrition 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 229960003949 dexpanthenol Drugs 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 229940096118 ella Drugs 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- MVPICKVDHDWCJQ-UHFFFAOYSA-N ethyl 3-pyrrolidin-1-ylpropanoate Chemical compound CCOC(=O)CCN1CCCC1 MVPICKVDHDWCJQ-UHFFFAOYSA-N 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 239000004459 forage Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 235000019674 grape juice Nutrition 0.000 description 1
- 235000013882 gravy Nutrition 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 229960001375 lactose Drugs 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 229940052490 naringin Drugs 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000006201 parenteral dosage form Substances 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- NCYCYZXNIZJOKI-OVSJKPMPSA-N retinal group Chemical group C\C(=C/C=O)\C=C\C=C(\C=C\C1=C(CCCC1(C)C)C)/C NCYCYZXNIZJOKI-OVSJKPMPSA-N 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 229940071220 retinyl linoleate Drugs 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229940045902 sodium stearyl fumarate Drugs 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 235000015193 tomato juice Nutrition 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- OOLLAFOLCSJHRE-ZHAKMVSLSA-N ulipristal acetate Chemical compound C1=CC(N(C)C)=CC=C1[C@@H]1C2=C3CCC(=O)C=C3CC[C@H]2[C@H](CC[C@]2(OC(C)=O)C(C)=O)[C@]2(C)C1 OOLLAFOLCSJHRE-ZHAKMVSLSA-N 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Birds (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
본 발명은 센티페드그라스(Eremochloa ophiuroides) 추출물, 이의 분획물 또는 상기 분획물로부터 분리한 활성분획을 유효성분으로 함유하는 피부 주름개선용 조성물에 관한 것으로, 더욱 상세하게는 센티페드그라스 추출물, 이의 분획물 또는 상기 분획물로부터 분리한 활성분획은 엘라스틴을 분해하는 엘라스타아제(elastase)의 저해 활성이 우수하므로 피부 주름개선용 조성물에 유용하게 사용될 수 있다.The present invention is sentigrass ( Eremochloa) ophiuroides ) extract, fractions thereof, or a composition for improving skin wrinkles containing the active fractions isolated from the fractions as an active ingredient, more specifically centifedgrass extract, fractions thereof or the active fractions separated from the fractions are elastin Since it has an excellent inhibitory activity of elastase that degrades it, it can be usefully used in a composition for improving skin wrinkles.
센티페드그라스(Eremochloa ophiuroides), 엘라스타아제(elastase), 주름개선 Sentipedgrass (Eremochloa ophiuroides), elastase, wrinkle improvement
Description
본 발명은 센티페드그라스 추출물 또는 이의 분획물을 유효성분으로 함유하는 피부 주름개선용 조성물에 관한 것이다.The present invention relates to a composition for improving skin wrinkles containing centipede glass extract or a fraction thereof as an active ingredient.
피부 주름 생성과 관련된 주요 기작은 피부가 대기오염, 자외선 노출, 스트레스 또는 질병 등의 유해환경으로부터 산화적 스트레스(oxidative stress)에 계속적으로 노출되어 체내의 라디칼이 증가되고, 진피의 결합조직인 콜라겐(collagen), 엘라스틴(elastin), 히아루론산(hyaluronic aicd) 등을 파괴하여 피부의 일정 부위 침하현상(주름)을 일으킬 수 있는 것으로 설명된다. 또한 이러한 기작들은 세포막의 지질 부분을 산화시켜 세포의 파괴 현상을 일으켜 피부염, 여드름 또는 피부암 등의 질병을 유발할 수 있다. 이외에도 라디칼은 멜라닌 형성과정에 관여하여 기미, 주근깨 및 주름생성의 원인이 되기도 한다.The main mechanism involved in the formation of skin wrinkles is that the skin is continuously exposed to oxidative stress from harmful environment such as air pollution, UV exposure, stress or disease, increasing the radicals in the body, and collagen (collagen), which is the connective tissue of the dermis. ), Elastin, hyaluronic acid (hyaluronic aicd) can be destroyed by causing a certain part of the skin subsidence (wrinkling) is described. In addition, these mechanisms can oxidize the lipid portion of the cell membrane and cause cell destruction, leading to diseases such as dermatitis, acne or skin cancer. In addition, radicals are involved in the process of melanin formation, causing spots, freckles and wrinkles.
이러한 피부 주름 개선을 위해서 기존에는 아스코르브산, α-토코페롤, 레티놀 및 그 유도체, 수퍼옥사이드 디스뮤타아제(Super Oxide Dismutase, SOD) 등이 자유 라디칼 소거 기능 또는 피부 주름 개선을 위한 물질로 화장료 또는 의약품에 배합되어 주름 및 기타 피부 질환을 방지하기 위하여 이용되어 왔으나, 이들은 가격이 고가일 뿐만 아니라 화학적 안정성이 좋지 못하여 실질적인 효과를 기대하기가 어려운 문제점이 있다. 이러한 이유로 보다 안전하면서 피부 주름 개선에 효과가 높은 물질을 개발하는 것이 의약품이나 식품 분야 뿐만 아니라 화장품 산업 분야에서도 중요한 과제로 대두되어 많은 연구가 진행되고 있다.To improve skin wrinkles, ascorbic acid, α-tocopherol, retinol and derivatives thereof, and superoxide dismutase (SOD) have been used in cosmetics or pharmaceuticals as substances for improving free radical scavenging or skin wrinkles. Although it has been used in combination to prevent wrinkles and other skin diseases, they are not only expensive, but also have poor chemical stability, which makes it difficult to expect a substantial effect. For this reason, the development of a safer and more effective material for improving skin wrinkles has emerged as an important task not only in the pharmaceutical and food sectors but also in the cosmetics industry.
피부 주름개선 화장료에 사용되는 레티노이드에는 레티놀(retinol), 레티날(retinal), 레틴산(retinoic acid), 레티닐 아세테이트(retinyl acetate), 레티닐 리놀리에이트(retinyl linoleate) 및 레티닐 팔미테이트(retinyl palmitate) 등이 있다. 이들 중 레티놀은 인체에 자연적으로 존재하는 내인성 화합물로서 상피 조직의 분화와 성장에 필수적인 물질이며, 레틴산 등의 레티노이드에 비해 매우 높은 안전성을 가지고 있어 피부 주름 개선 화장료의 원료로서 매우 적합하다고 할 수 있다.Retinoids used in skin antiwrinkle cosmetics include retinol, retinal, retinoic acid, retinyl acetate, retinyl linoleate and retinyl palmitate ( retinyl palmitate). Among these, retinol is an endogenous compound that is naturally present in the human body and is essential for the differentiation and growth of epithelial tissues.It has very high safety compared to retinoids such as retinic acid, and thus is suitable as a raw material for skin wrinkle improvement cosmetics. .
이러한 레티노이드는 피부 주름개선에 효능이 있는 것으로 피부 임상을 통하여 검증되었지만 제품에 처방될 경우 변색, 변취 현상이 발생하고, 소량 사용시에도 피부 자극이 유발되는 부작용이 있으며, 경시적인 변화에 의한 역가 감소와 이 에 따른 효과 감소 등이 큰 문제점으로 인식되고 있다.These retinoids have been proven to be effective in improving wrinkles on the skin, but when prescribed in the product, discoloration and odor occur, and skin irritation occurs even when used in small amounts. The reduction of the effect is recognized as a big problem.
이러한 레티노이드의 문제점들을 극복하기 위해 천연물 유래 생리 활성 물질들을 이용한 주름개선용 화장료의 개발이 필요하다. 이는 레티노이드에 비하여 피부 부작용이 적고, 경시적인 화학적 변화가 적어 화장료의 안전성 및 안정성이 우수하다는 장점이 있다. 따라서, 피부 주름개선용 화장료로 약용 식물 자원들에 대한 연구가 지속되고 있다. In order to overcome the problems of the retinoids, it is necessary to develop a cosmetic for improving wrinkles using natural-derived bioactive substances. This has the advantage of less skin side effects, less chemical changes over time compared to retinoids, excellent safety and stability of cosmetics. Therefore, research on medicinal plant resources as a cosmetic for skin wrinkle improvement continues.
센티페드그라스(Eremochloa ophiuroides)는 생육이 늦은 난지형 잔디로서 뗏장을 형성하며 포복 생장을 하는 다년생 잔디이다. Poaceae과에 속하며, 학명은 Eremochloa ophiuroides (Munro) Hack이다. 주로 중국과 동아시아, 인도차이나, 미국 북동부, 메소아메리카와 캐러비안 지역에 분포하고 있으며, 각종 토양조건에 폭 넓게 잘 적응되지만, 특히 습하며 산성토양 및 비옥도가 낮은 사질 토양에서 잘 견딘다.Sentipedgrass ( Eremochloa ophiuroides ) is a slow growing turbulent turf, a perennial grass that crawls and forms turf. It belongs to the Poaceae family and its scientific name is Eremochloa ophiuroides (Munro) Hack. It is mainly distributed in China, East Asia, Indochina, the northeastern United States, Meso America, and the Caribbean, and is widely adapted to various soil conditions, but is especially resistant to moist, low acidic soils and low-quality sandy soils.
형태학적 특징으로서, 잎은 길이 15~30 ㎜, 폭 2~4 ㎜이고, 흰 중심맥(mid vein)을 가지는 납작한 모양이며, 경령(collar) 부분을 제외하고 털이 없고, 잎 끝부분은 둥글다. 줄기는 아주 굳게 다문 잎집(sheath)을 가지고, 뿌리는 가는 분기형의 포복경(stolons)이다. 꽃 부분은 3~5 인치 정도의 하나의 총상화서(總狀花序, raceme, = 총상꽃차례)를 가지고, 상기 총상화서는 자줏빛색을 띠고 약간 평평하며 두 줄로 배열된 작은 이삭(小穗, spikelet)을 가진다. 주용도는 잔디 밭 또 는 뗏장 잔디로 사용되고 높은 잎의 비율(leafiness)과 좋은 맛 때문에 조사료로 이용된다. As a morphological feature, the leaves are 15-30 mm long, 2-4 mm wide, flat with a mid vein, hairless except for the collar part, and the leaf ends are round. The stem has a very firm sheath, and the roots are thin branched stolons. The flower part has one raceme of about 3 to 5 inches, which has a purple, slightly flat, small spikelet arranged in two rows. Have Its main use is as a lawn or turf grass and as a forage due to its high leafiness and good taste.
이에 본 발명자들은 피부 주름개선을 위한 천연 식물 추출물을 개발하고자 연구한 결과, 센티페드그라스에서 추출한 추출물, 이의 분획물 및 상기 분획물로부터 분리한 활성분획이 엘라스타아제(elastase) 저해 활성을 가지므로 피부 주름개선용 조성물의 유효성분으로서 유용하게 사용될 수 있음을 밝힘으로써 본 발명을 완성하였다. Therefore, the present inventors have studied to develop a natural plant extract for skin wrinkle improvement, the skin extract, the extract extracted from Sentipedgrass, its fractions and the active fractions separated from the fractions have an elastase inhibitory activity The present invention has been completed by revealing that it can be usefully used as an active ingredient of the composition for improvement.
본 발명의 목적은 센티페드그라스(Eremochloa ophiuroides) 추출물 또는 이의 분획물을 유효성분으로 함유하는 피부 주름개선용 조성물을 제공하는 것이다. The object of the present invention is Centipedgrass ( Eremochloa) It is to provide a composition for improving skin wrinkles containing ophiuroides ) extract or a fraction thereof as an active ingredient.
상기 목적을 달성하기 위하여, 본 발명은 센티페드그라스 추출물, 이의 분획물 또는 상기 분획물로부터 분리한 활성분획을 유효성분으로 함유하는 피부 주름개선용 화장료 조성물을 제공한다.In order to achieve the above object, the present invention provides a cosmetic composition for improving skin wrinkles containing centipede glass extract, a fraction thereof or an active fraction separated from the fraction as an active ingredient.
또한, 본 발명은 센티페드그라스 추출물, 이의 분획물 또는 상기 분획물로부터 분리한 활성분획을 유효성분으로 함유하는 피부 주름개선용 약학적 조성물을 제공한다.In another aspect, the present invention provides a pharmaceutical composition for skin wrinkle improvement containing the centipedes grass extract, fractions thereof or active fractions isolated from the fractions as an active ingredient.
아울러, 본 발명은 센티페드그라스 추출물, 이의 분획물 또는 상기 분획물로부터 분리한 활성분획을 유효성분으로 함유하는 피부 주름개선용 건강식품을 제공한다.In addition, the present invention provides a skin wrinkle improvement health food containing the centifed glass extract, a fraction thereof or an active fraction separated from the fraction as an active ingredient.
센티페드그라스 추출물, 이의 분획물 또는 상기 분획물로부터 분리한 활성분획은 엘라스틴을 파괴하는 엘라스타아제를 저해하는 활성이 있으므로 피부 주름개선용 조성물로 유용하게 사용될 수 있다.Centipedgrass extract, fractions thereof or active fractions isolated from the fractions can be usefully used as a composition for improving skin wrinkles because they have an activity of inhibiting elastase that destroys elastin.
이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명은 센티페드그라스 추출물, 이의 분획물 또는 상기 분획물로부터 분리한 활성분획을 유효성분으로 함유하는 피부 주름개선용 화장료 조성물을 제공한다.The present invention provides a cosmetic composition for improving skin wrinkles containing centipede glass extract, a fraction thereof or an active fraction separated from the fraction as an active ingredient.
상기 센티페드그라스 추출물은 하기의 단계들을 포함하는 제조방법에 의해 제조되는 것이 바람직하나 이에 한정하지 않는다: The centipedes grass extract is preferably prepared by a manufacturing method comprising the following steps, but not always limited thereto:
1) 센티페드그라스에 추출용매를 가하여 추출하는 단계;1) extracting by adding an extracting solvent to centipede glass;
2) 단계 1)의 추출물을 식힌 후 여과하는 단계; 및2) cooling the extract of step 1) and filtering; And
3) 단계 2)의 여과한 추출물을 감압농축하는 단계.3) concentrating the filtered extract of step 2) under reduced pressure.
상기 방법에 있어서, 단계 1)의 센티페드그라스는 재배한 것 또는 시판되는 것 등 제한 없이 사용할 수 있다. 상기 센티페드그라스는 잎을 이용하는 것이 바람직하나 이에 한정하지 않는다.In the above method, the centipedes of step 1) can be used without limitation, such as those grown or commercially available. The centifed grass is preferably used as a leaf, but is not limited thereto.
상기 추출용매는 물, 알코올 또는 이들의 혼합물을 사용하는 것이 바람직하다. 상기 알코올로는 C1 내지 C4의 저급 알코올을 이용하는 것이 바람직하며, 저급 알코올로는 에탄올 또는 메탄올을 이용하는 것이 바람직하다. 추출방법으로는 진탕추출 또는 환류추출을 이용하는 것이 바람직하나 이에 한정하지 않는다. 상기 추출용매를 센티페드그라스 분량에 2 내지 10배 첨가하여 추출하는 것이 바람직하나 이에 한정하지 않는다. 추출온도는 50 내지 100℃인 것이 바람직하나 이에 한정하지 않는다. 또한, 추출시간은 2 내지 5일인 것이 바람직하나 이에 한정하지 않는다. 아울러, 추출 회수는 1 내지 3회인 것이 바람직하나 이에 한정하지 않는다. The extraction solvent is preferably water, alcohol or a mixture thereof. As the alcohol, C 1 to C 4 lower alcohols are preferably used, and as the lower alcohols, ethanol or methanol is preferably used. As the extraction method, it is preferable to use shaking extraction or reflux extraction, but not always limited thereto. The extraction solvent is preferably extracted by adding 2 to 10 times the amount to the centipedes glass, but is not limited thereto. Extraction temperature is preferably 50 to 100 ℃ but is not limited thereto. In addition, the extraction time is preferably 2 to 5 days, but is not limited thereto. In addition, the extraction number is preferably one to three times, but is not limited thereto.
상기 방법에 있어서, 단계 3)의 감압농축은 진공감압농축기 또는 진공회전증발기를 이용하는 것이 바람직하나 이에 한정하지 않는다. 또한, 건조는 감압건조, 진공건조, 비등건조, 분무건조 또는 동결건조하는 것이 바람직하나 이에 한정하지 않는다.In the above method, it is preferable to use a vacuum decompression concentrator or a vacuum rotary evaporator for the decompression concentration in step 3), but it is not limited thereto. In addition, the drying is preferably reduced pressure drying, vacuum drying, boiling drying, spray drying or freeze drying, but is not limited thereto.
상기 센티페드그라스 추출물의 분획물 또는 상기 분획물로부터 분리한 활성분획은 하기의 단계들을 포함하는 제조방법에 의해 제조되는 것이 바람직하나 이에 한정하지 않는다:The fraction of the centifed glass extract or the active fraction separated from the fraction is preferably prepared by a manufacturing method comprising the following steps, but not always limited thereto:
1) 센티페드그라스 추출물에 추가로 유기용매를 가하여 유기용매 분획물을 제조하는 단계; 및1) adding an organic solvent to the centipedes glass extract to prepare an organic solvent fraction; And
2) 단계 1)의 분획물을 컬럼크로마토그래피를 실시하여 활성분획을 제조하는 단계.2) preparing an active fraction by subjecting the fraction of step 1) to column chromatography.
상기 방법에 있어서, 단계 1)의 유기용매는 에틸아세테이트인 것이 바람직하나 이에 한정하지 않는다.In the above method, the organic solvent of step 1) is preferably ethyl acetate, but not always limited thereto.
상기 방법에 있어서, 단계 2)의 컬럼크로마토그래피는 실리카겔, 세파덱스, RP-18, 폴리아미드, 도요펄(Toyopearl) 및 XAD 수지로 이루어진 그룹으로부터 선택 된 충진제를 이용한 컬럼크로마토그래피를 수행하여 활성분획을 분리 및 정제할 수 있다. 컬럼크로마토그래피는 필요에 따라 적절한 충진제를 선택하여 수차례 실시할 수 있다. In the above method, the column chromatography of step 2) is an active fraction by performing column chromatography using a filler selected from the group consisting of silica gel, Sephadex, RP-18, polyamide, Toyopearl and XAD resin. Can be isolated and purified. Column chromatography can be carried out several times by selecting an appropriate filler as necessary.
본 발명자들은 센티페드그라스의 에틸아세테이트 분획물을 Flex-ColumTM(3 ㎝ × 25 ㎝) 및 도요펄(Toyoperarl) HW-40(75 ㎛) 컬럼크로마토그래피에 흡착시키고 20, 50 또는 70% 메탄올 용출용매를 사용하여, 에틸아세테이트-20%메탄올, 에틸아세테이트-50%메탄올 및 에틸아세테이트-70%메탄올 활성분획을 얻었다. We adsorbed the ethyl acetate fractions of centifedgrass to Flex-Colum ™ (3 cm × 25 cm) and Toyoperarl HW-40 (75 μm) column chromatography and dissolved 20, 50 or 70% methanol. Using ethyl acetate-20% methanol, ethyl acetate-50% methanol and ethyl acetate-70% methanol were obtained.
상기 센티페드그라스 추출물은 하기 화학식 1 내지 화학식 8로 표시되는 화합물로 구성된 군으로부터 선택된 화합물들 중 어느 하나 이상을 포함하는 것이 바람직하나 이에 한정하지 않는다(도 2 참조).The centipedes grass extract preferably includes any one or more of compounds selected from the group consisting of compounds represented by the following Chemical Formulas 1 to 8, but is not limited thereto.
상기 센티페드그라스 추출물의 분획물로부터 분리한 활성분획은 하기 화학식 4 내지 화학식 8로 표시되는 화합물로 구성된 군으로부터 선택된 화합물들 중 어느 하나 이상을 포함하는 것이 바람직하나 이에 한정하지 않는다(도 3, 도 4, 및 도 5 참조).The active fraction separated from the fraction of the centipedes grass extract preferably includes any one or more of compounds selected from the group consisting of compounds represented by the following formulas (4) to (8) (but not limited thereto) , And FIG. 5).
본 발명자들은 센티페드그라스 추출물의 피부 주름개선 효과를 알아보기 위하여 센티페드그라스 추출물의 농도(20, 200, 2000 또는 4000 ㎍/㎖)에 따른 엘라 스타아제(elastase) 저해 활성을 피부 주름개선 활성이 뛰어난 것으로 기존에 잘 알려진 옥수수수염 추출물과 비교하여 측정하였다. 그 결과, 20 ~ 4000 ㎍/㎖의 농도에서 센티페드그라스 추출물의 엘라스타아제 저해 활성은 메탄올 추출물이 각각 약 24, 50, 91 및 93%, 에탄올 추출물이 각각 약 23, 50, 90 및 92%, 물 추출물이 각각 약 23, 49, 90 및 91%로 나타났고, 옥수수수염 메탄올 추출물은 상기와 같은 농도에서 각각 약 8, 17, 59 및 75%의 엘라스타아제 저해 활성을 나타냈다(표 2 및 도 6 참조). 따라서 센티페드그라스 추출물이 옥수수수염 추출물에 비해 현저히 뛰어난 피부 주름개선 효과가 있음을 알 수 있다. In order to investigate the skin wrinkle improvement effect of centifed glass extract, the present inventors found that elastase inhibitory activity according to the concentration of centifed glass extract (20, 200, 2000 or 4000 ㎍ / ml) was applied to the skin wrinkle improvement activity. It was measured in comparison with the well-known corn beard extract which was known to be excellent. As a result, the elastase inhibitory activity of the centipedes grass extract at concentrations of 20 to 4000 μg / ml was about 24, 50, 91 and 93% for methanol extracts and about 23, 50, 90 and 92% for ethanol extracts, respectively. , Water extracts of about 23, 49, 90 and 91%, respectively, and the corncoal methanol extract showed about 8, 17, 59 and 75% of elastase inhibitory activity at the same concentrations (Table 2 and 6). Therefore, it can be seen that the centipedes grass extract has a significantly better skin wrinkle improvement effect than the corn beard extract.
본 발명자들은 센티페드그라스 추출물, 이의 분획물 또는 상기 분획물로부터 분리한 활성분획의 피부 주름개선 효과를 알아보기 위해, 4000 ㎍/㎖의 센티페드그라스 추출물, 이의 분획물 또는 상기 분획물로부터 분리한 활성분획의 엘라스타아제 저해 활성을 측정하였다. 그 결과, 센티페드그라스 추출물은 약 96 ~ 98%의 엘라스타아제 저해 활성을 나타냈고, 에틸아세테이트 분획물의 활성분획은 약 92%의 엘라스타아제 저해 활성을 나타냈다(표 3 및 도 7 참조). The inventors of the present invention, in order to determine the skin wrinkle improvement effect of the centifed glass extract, fractions thereof or the active fractions isolated from the fractions, the ella of 4000 ㎍ / ㎖ Centifgrass grass extracts, fractions or active fractions separated from the fractions Statase inhibitory activity was measured. As a result, the centipedes grass extract showed about 96-98% elastase inhibitory activity, and the active fraction of the ethyl acetate fraction showed about 92% elastase inhibitory activity (see Table 3 and FIG. 7).
따라서 센티페드그라스 추출물, 이의 분획물 또는 상기 분획물로부터 분리한 활성분획이 현저한 주름개선 효과를 가지므로 피부 주름개선에 효과적인 화장료 조성물로서 유용하게 사용될 수 있다. Therefore, the centipedes grass extract, fractions thereof or the active fractions separated from the fractions have a significant anti-wrinkle effect, and thus may be usefully used as an effective cosmetic composition for skin wrinkle improvement.
상기 화장료 조성물은, 예를 들면 용액, 겔, 고체 또는 반죽 무수 생성물, 수상에 유상을 분산시켜 얻은 에멀젼, 현탁액, 마이크로에멀젼, 마이크로캡슐, 미세과립구 또는 이온형(리포좀), 비이온형의 소낭 분산제의 형태, 크림, 스킨, 로 션, 파우더, 연고, 스프레이 또는 콘실 스틱의 형태로 제공될 수 있다. 또한, 포말(foam)의 형태 또는 압축된 추진제를 더 함유한 에어로졸 조성물의 형태로도 제조될 수 있다.The cosmetic composition is, for example, emulsions, suspensions, microemulsions, microcapsules, microgranules or ionic (liposomes), nonionic vesicle dispersants obtained by dispersing an oil phase in a solution, a gel, a solid or pasty anhydrous product, or an aqueous phase. It may be provided in the form of creams, skins, lotions, powders, ointments, sprays or concealed sticks. It may also be prepared in the form of a foam or in the form of an aerosol composition further containing a compressed propellant.
또한, 상기 화장료 조성물은 본 발명의 센티페드그라스 추출물, 이의 분획물 또는 상기 분획물로부터 분리한 활성분획에 추가로 지방 물질, 유기 용매, 용해제, 농축제 및 겔화제, 연화제, 항산화제, 현탁화제, 안정화제, 발포제(foaming agent), 방향제, 계면활성제, 물, 이온형 또는 비이온형 유화제, 충전제, 금속이온봉쇄제 및 킬레이트화제, 보존제, 비타민, 차단제, 습윤화제, 필수 오일, 염료, 안료, 친수성 또는 친유성 활성제, 지질 소낭 또는 화장품에 통상적으로 사용되는 임의의 다른 성분과 같은 화장품 분야에서 통상적으로 사용되는 보조제를 함유할 수 있다.In addition, the cosmetic composition, in addition to the centipedes grass extract of the present invention, fractions thereof or the active fraction separated from the fractions, fatty substances, organic solvents, solubilizers, thickening and gelling agents, emollients, antioxidants, suspending agents, stabilizers Agents, foaming agents, fragrances, surfactants, water, ionic or nonionic emulsifiers, fillers, metal ion sequestrants and chelating agents, preservatives, vitamins, blockers, wetting agents, essential oils, dyes, pigments, hydrophilic Or adjuvants commonly used in the cosmetic field, such as lipophilic actives, lipid vesicles, or any other ingredient conventionally used in cosmetics.
본 발명의 센티페드그라스 추출물, 이의 분획물 또는 상기 분획물로부터 분리한 활성분획을 함유하는 화장료 조성물에 있어서, 통상적으로 함유되는 화장료 조성물에 본 발명의 추출물이 1 내지 15 중량%, 바람직하게는 2 내지 10 중량%의 양으로 첨가될 수 있다.In the cosmetic composition containing the centipede grass extract of the present invention, a fraction thereof or an active fraction separated from the fraction, in the cosmetic composition usually contained 1 to 15% by weight, preferably 2 to 10 It can be added in an amount by weight.
본 발명의 센티페드그라스 추출물, 이의 분획물 또는 상기 분획물로부터 분리한 활성분획을 피부 외용제로 사용하는 경우, 추가로 지방 물질, 유기 용매, 용해제, 농축제 및 겔화제, 연화제, 항산화제, 현탁화제, 안정화제, 발포제(foaming agent), 방향제, 계면활성제, 물, 이온형 또는 비이온형 유화제, 충전제, 금속이온봉쇄제 및 킬레이트화제, 보존제, 비타민, 차단제, 습윤화제, 필수 오일, 염료, 안 료, 친수성 또는 친유성 활성제, 지질 소낭 또는 피부용 외용제에 통상적으로 사용되는 임의의 다른 성분과 같은 피부 과학 분야에서 통상적으로 사용되는 보조제를 함유할 수 있다. 또한, 상기 성분들은 피부 과학 분야에서 일반적으로 사용되는 양으로 도입될 수 있다.In the case of using the centipedes grass extract of the present invention, fractions thereof, or active fractions separated from the fractions as external preparations for skin, additionally, fatty substances, organic solvents, solubilizers, thickening and gelling agents, emollients, antioxidants, suspending agents, Stabilizers, foaming agents, fragrances, surfactants, water, ionic or nonionic emulsifiers, fillers, metal ion sequestrants and chelating agents, preservatives, vitamins, blockers, wetting agents, essential oils, dyes, pigments , Hydrophilic or lipophilic actives, lipid vesicles, or any other ingredient commonly used in external preparations for skin, may contain adjuvants commonly used in the field of dermatology. In addition, the ingredients may be introduced in amounts generally used in the field of dermatology.
또한, 본 발명은 센티페드그라스 추출물, 이의 분획물 또는 상기 분획물로부터 분리한 활성분획을 유효성분으로 함유하는 피부 주름개선용 약학적 조성물을 제공한다. In another aspect, the present invention provides a pharmaceutical composition for skin wrinkle improvement containing the centipedes grass extract, fractions thereof or active fractions isolated from the fractions as an active ingredient.
본 발명의 센티페드그라스 추출물, 이의 분획물 또는 상기 분획물로부터 분리한 활성분획은 엘라스타아제 저해 활성을 가짐을 확인하여, 피부 주름개선 효과가 뛰어난 것으로 나타났으므로 효과적인 피부 주름개선용 약학적 조성물로서 유용하게 사용될 수 있다.Centifedgrass extract, fractions thereof, or active fractions isolated from the fractions of the present invention were found to have elastase inhibitory activity and were found to have excellent skin anti-wrinkle effect, which is useful as an effective pharmaceutical composition for skin anti-wrinkle improvement. Can be used.
본 발명의 약학적 조성물은 통상적으로 사용되는 부형제, 붕해제, 감미제, 활택제, 향미제 등을 추가로 포함할 수 있으며, 통상적인 방법에 의해 정제, 캅셀제, 산제, 과립제, 현탁제, 유제, 시럽제, 기타 액제로 제형화될 수 있다.The pharmaceutical composition of the present invention may further include conventionally used excipients, disintegrants, sweeteners, lubricants, flavoring agents, etc., tablets, capsules, powders, granules, suspensions, emulsions, It can be formulated into syrups, other liquids.
구체적으로 본 발명의 약학적 조성물은 경구 투여용 제형, 예를 들면 정체, 트로치제(troches), 로젠지(lozenge), 수용성 또는 우성현탁액, 조제분말 또는 과립, 에멀젼, 하드 또는 소프트 캡슐, 시럽 또는 엘릭시르제(elixirs)로 제제화된다. 정제 및 캡슐 등의 제형으로 제제하기 위해 락토오스, 사카로오스, 솔비톨, 만니톨, 전분, 아밀로펙틴, 셀롤로오스 또는 젤라틴과 같은 결합제, 디칼슘 포스페 이트와 같은 부형제, 옥수수 전분 또는 고구마 전분과 같은 붕해제, 스테아르산 마그네슘, 스테아르산 칼슘, 스테아릴푸마르산 나트륨 또는 폴리에틸렌글리콜 왁스와 같은 윤활유가 함유된다. 캡슐제형의 경우는 상기에서 언급한 물질 이외에도 지방유와 같은 액체 담체를 함유한다.In particular, the pharmaceutical compositions of the present invention may be formulated for oral administration such as, for example, stagnation, troches, lozenges, aqueous or dominant suspensions, prepared powders or granules, emulsions, hard or soft capsules, syrups or It is formulated with elixirs. Lactose, saccharose, sorbitol, mannitol, starch, amylopectin, binders such as cellulose or gelatin, excipients such as dicalcium phosphate, disintegrants such as corn starch or sweet potato starch, for formulation into formulations such as tablets and capsules, Lubricants such as magnesium stearate, calcium stearate, sodium stearyl fumarate or polyethylene glycol wax. In the case of a capsule formulation, in addition to the above-mentioned substances, a liquid carrier such as fatty oil is contained.
또한, 본 발명의 약학적 조성물은 경구 또는 비경구 투여할 수 있으며, 비경구 투여시 피하주사, 정맥주사, 근육내 주사 또는 흉부내 주사 주입방식을 선택하는 것이 바람직하다. 비경구 투여용 제형으로 제제화하기 위해서는 본 발명의 센티페드그라스 추출물, 이의 분획물 또는 분획물의 활성분획을 안정제 또는 완충제와 함께 물에서 혼합하여 현탁액으로 제조하고 이를 앰플 또는 바이알의 단위 투여형으로 제제한다.In addition, the pharmaceutical composition of the present invention may be administered orally or parenterally, and it is preferable to select subcutaneous injection, intravenous injection, intramuscular injection, or intrathoracic injection injection method. To formulate into parenteral dosage forms, the centifedgrass extract, fractions or active fractions thereof of the present invention are mixed in water with stabilizers or buffers to prepare a suspension and formulated in unit dosage forms of ampoules or vials.
본 발명에 따른 유효성분의 투여량은 체내에서 활성성분의 흡수도, 불활성화율 및 배설속도, 환자의 연령, 성별 및 상태, 치료할 질병의 중증 정도에 따라 적절히 선택되나, 경구 투여제의 경우 일반적으로 성인에게 1일에 체중 1 ㎏당 본 발명의 추출물을 0.0001 ~ 500 ㎎의 양으로 1회 내지 수회 나누어 투여할 수 있으며, 0.001 ~ 100 ㎎의 양으로 투여하는 것이 바람직하다.The dosage of the active ingredient according to the present invention is appropriately selected according to the absorption rate, inactivation rate and excretion rate of the active ingredient in the body, the age, sex and condition of the patient, the severity of the disease to be treated, but in the case of oral administration in general Adults can be administered once to several times in an amount of 0.0001 to 500 mg of the extract of the present invention per kg of body weight per day, it is preferable to administer in an amount of 0.001 to 100 mg.
아울러, 본 발명은 센티페드그라스 추출물, 이의 분획물 또는 상기 분획물로부터 분리한 활성분획을 유효성분으로 함유하는 피부 주름개선용 건강식품을 제공한다.In addition, the present invention provides a skin wrinkle improvement health food containing the centifed glass extract, a fraction thereof or an active fraction separated from the fraction as an active ingredient.
본 발명의 센티페드그라스 추출물, 이의 분획물 또는 상기 분획물로부터 분 리한 활성분획은 엘라스타아제 저해 활성을 가지므로 효과적인 피부 주름개선용 건강식품으로서 유용하게 사용될 수 있다.Centifed glass extract, fractions thereof, or active fractions separated from the fractions of the present invention have elastase inhibitory activity and thus can be usefully used as an effective food for skin wrinkle improvement.
본 발명의 건강식품은 센티페드그라스 추출물, 이의 분획물 또는 상기 분획물로부터 분리한 활성분획을 그대로 첨가하거나 다른 식품 또는 식품 성분과 함께 사용될 수 있고, 통상적인 방법에 따라 적절하게 사용될 수 있다.The health food of the present invention may be added to the centipedes grass extract, fractions thereof, or active fractions separated from the fractions as it is, or used with other foods or food ingredients, and may be appropriately used according to conventional methods.
상기 식품의 종류에는 특별한 제한은 없다. 상기 센티페드그라스 추출물, 이의 분획물 또는 상기 분획물로부터 분리한 활성분획을 첨가할 수 있는 식품의 예로는 육류, 소시지, 빵, 초콜릿, 캔디류, 스넥류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차, 드링크제, 알코올음료 및 비타민 복합제 등이 있으며, 통상적인 의미에서의 건강식품을 모두 포함한다.There is no particular limitation on the kind of food. Examples of foods to which the centifed grass extract, fractions thereof, or active fractions separated from the fractions may be added include meat, sausage, bread, chocolate, candy, snacks, confectionary, pizza, ramen, other noodles, gum, and ice cream. Dairy products, including various soups, beverages, tea, drinks, alcoholic beverages and vitamin complexes, and the like, includes all of the health food in the usual sense.
본 발명의 건강 음료 조성물은 통상의 음료와 같이 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다. 상술한 천연 탄수화물은 포도당, 과당과 같은 모노사카라이드, 말토스, 슈크로스와 같은 디사카라이드, 및 덱스트린, 사이클로덱스트린과 같은 폴리사카라이드, 자일리톨, 소르비톨, 에리트리톨 등의 당알콜이다. 감미제로서는 타우마틴, 스테비아 추출물과 같은 천연 감미제나, 사카린, 아스파르탐과 같은 합성 감미제 등을 사용할 수 있다. 상기 천연 탄수화물의 비율은 본 발명의 조성물 100 ㎖당 일반적으로 약 0.01 ~ 0.04 g, 바람직하게는 약 0.02 ~ 0.03 g 이다.The health beverage composition of the present invention may contain various flavors, natural carbohydrates, and the like as additional components, as in a conventional beverage. Such natural carbohydrates are monosaccharides such as glucose and fructose, disaccharides such as maltose and sucrose, and polysaccharides such as dextrin and cyclodextrin, and sugar alcohols such as xylitol, sorbitol and erythritol. Examples of sweeteners include natural sweeteners such as tau martin and stevia extract, synthetic sweeteners such as saccharin and aspartame, and the like. The proportion of the natural carbohydrate is generally about 0.01 to 0.04 g, preferably about 0.02 to 0.03 g per 100 ml of the composition of the present invention.
상기 외에 본 발명의 센티페드그라스 추출물, 이의 분획물 또는 상기 분획물 로부터 분리한 활성분획은 여러 가지 영양제, 비타민, 전해질, 풍미제, 착색제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산음료에 사용되는 탄산화제 등을 함유할 수 있다. 그 밖에 본 발명의 센티페드그라스 추출물, 이의 분획물 또는 상기 분획물의 활성분획은 천연 과일 주스, 과일 주스 음료 및 야채 음료의 제조를 위한 과육을 함유할 수 있다. 이러한 성분은 독립적으로 또는 혼합하여 사용할 수 있다. 이러한 첨가제의 비율은 크게 중요하진 않지만 본 발명의 조성물 100 중량부당 0.01 ~ 0.1 중량부의 범위에서 선택되는 것이 일반적이다.In addition to the above, the centifedgrass extract, fractions thereof, or active fractions separated from the fractions of the present invention may contain various nutrients, vitamins, electrolytes, flavors, colorants, pectic acids and salts thereof, alginic acid and salts thereof, organic acids, protective colloids. Thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohols, carbonation agents used in carbonated drinks and the like. In addition, the centifedgrass extract, fractions thereof or active fractions of the present invention may contain pulp for the production of natural fruit juices, fruit juice drinks and vegetable drinks. These components can be used independently or in combination. The proportion of such additives is not critical but is generally selected in the range of 0.01 to 0.1 parts by weight per 100 parts by weight of the composition of the present invention.
이하, 본 발명을 실시예, 실험예, 비교예 및 제조예에 의하여 상세히 설명한다. Hereinafter, the present invention will be described in detail by Examples, Experimental Examples, Comparative Examples and Preparation Examples.
단, 하기 실시예, 실험예, 비교예 및 제조예는 본 발명을 구체적으로 예시하는 것이며, 본 발명의 내용이 실시예, 실험예, 비교예 및 제조예에 의해 한정되는 것은 아니다.However, the following Examples, Experimental Examples, Comparative Examples, and Production Examples specifically illustrate the present invention, and the content of the present invention is not limited to Examples, Experimental Examples, Comparative Examples, and Production Examples.
<< 실시예Example 1> 1> 센티페드그라스Sentipedgrass 추출물의 제조 Preparation of Extract
<1-1> <1-1> 센티페드그라스Sentipedgrass 메탄올 추출물의 제조 Preparation of Methanol Extracts
센티페드그라스 종자를 일본의 Fukukaen Nursery and Blub co. Ltd로부터 수입하여 한국원자력연구원 정읍 방사선과학연구소의 포장에서 증식하여 센티페드그 라스 잎 시료를 채취하였다. 채취한 잎 시료는 -80℃에 보관하여 사용하였다. 센티페드그라스 잎 5 ㎏ 을 100% 메탄올(MeOH) 20 ℓ를 첨가하여 믹서기로 마쇄한 후 상온에서 3일간 침지시켜 얻은 추출물을 50℃에서 감압 농축하여 210 g의 센티페드그라스 메탄올 추출물을 수득하였다. Sentipedgrass seeds from Fukukaen Nursery and Blub co. It was imported from the Korea Atomic Energy Research Institute, and was grown on the pavement of Jeongeup Radiation Science Research Institute. The collected leaf samples were stored and used at -80 ° C. 5 kg of centipedgrass leaves were added to 20 L of 100% methanol (MeOH) and crushed in a blender, and then the extract obtained by immersion at room temperature for 3 days was concentrated under reduced pressure at 50 ° C. to obtain 210 g of centipedes methanol extract.
<1-2> <1-2> 센티페드그라스Sentipedgrass 에탄올 추출물의 제조 Preparation of Ethanol Extract
센티페드그라스 종자를 일본의 Fukukaen Nursery and Blub co. Ltd로부터 수입하여 한국원자력연구원 정읍 방사선과학연구소의 포장에서 증식하여 센티페드그라스 잎 시료를 채취하였다. 채취한 잎 시료는 -80℃에 보관하여 사용하였다. 센티페드그라스 잎 5 ㎏ 을 100% 에탄올(EtOH) 20 ℓ를 첨가하여 믹서기로 마쇄한 후 상온에서 3일간 침지시켜 얻은 추출물을 50℃에서 감압 농축하여 203 g의 센티페드그라스 에탄올 추출물을 수득하였다. Sentipedgrass seeds from Fukukaen Nursery and Blub co. Ltd. was imported from the Korea Atomic Energy Research Institute Chung-eup Institute of Radiation Science Research Institute and collected from the Centipedgrass leaf. The collected leaf samples were stored and used at -80 ° C. 5 kg of centipedgrass leaves were added to 20 L of 100% ethanol (EtOH) and crushed with a blender, and then the extract obtained by immersion at room temperature for 3 days was concentrated under reduced pressure at 50 ° C. to obtain 203 g of centipedes ethanol extract.
<1-3> <1-3> 센티페드그라스Sentipedgrass 물 추출물의 제조 Preparation of Water Extract
센티페드그라스 종자를 일본의 Fukukaen Nursery and Blub co. Ltd로부터 수입하여 한국원자력연구원 정읍 방사선과학연구소의 포장에서 증식하여 센티페드그라스 잎 시료를 채취하였다. 채취한 잎 시료는 -80℃에 보관하여 사용하였다. 센티페드그라스 잎 5 ㎏ 을 물 20 ℓ를 첨가하여 믹서기로 마쇄한 후 상온에서 3일간 침지시켜 얻은 추출물을 50℃에서 감압 농축하여 198 g의 센티페드그라스 물 추출물을 수득하였다. Sentipedgrass seeds from Fukukaen Nursery and Blub co. Ltd. was imported from the Korea Atomic Energy Research Institute Chung-eup Institute of Radiation Science Research Institute and collected from the Centipedgrass leaf. The collected leaf samples were stored and used at -80 ° C. 5 kg of centipedgrass leaves were added to 20 liters of water, and crushed by a blender. The extract obtained by immersion at room temperature for 3 days was concentrated under reduced pressure at 50 ° C. to obtain 198 g of centipedes glass water extract.
<< 실시예Example 2> 2> 센티페드그라스Sentipedgrass 분획물Fraction 및 활성분획의 제조 And preparation of active fractions
상기 <실시예 1-1>에서 수득한 센티페드그라스 메탄올 추출물을 유기용매를 사용하여 극성에 따른 분획을 실시하였다. [도 1]과 같이, 감압농축한 메탄올 추출물을 물에 현탁한 후, 저극성 용매인 헥산(N- Hexane)으로 먼저 추출한 후 물층을 다시 에틸아세테이트(EtOAc)로 분획하였다. 두 용액으로 분획한 후 물에 의한 가용 분획물을 마지막으로 수득하였다. 각 용매추출 분획을 감압농축하여 건조시킨 후, 에틸아세테이트 분획물(21 g)을 얻었다. The centifed glass methanol extract obtained in Example 1-1 was fractionated according to polarity using an organic solvent. As shown in FIG. 1, the concentrated methanol extract was suspended in water, first extracted with hexane (N-Hexane), which is a low polar solvent, and the water layer was partitioned with ethyl acetate (EtOAc). After partitioning into two solutions, a soluble fraction with water was finally obtained. The solvent extract fractions were concentrated under reduced pressure and dried to obtain an ethyl acetate fraction (21 g).
에틸아세테이트 분획물을 20%, 50% 또는 70% 메탄올을 용출용매로 사용하여 Flex-Colum TM(3 ㎝×25 ㎝)과 Toyoperarl HW-40(75 ㎛)를 사용하여 컬럼크로마토그래피를 실시하였으며, 에틸아세테이트-20%메탄올(9.41 g), 에틸아세테이트-50%메탄올(5.74 g) 및 에틸아세테이트-70%메탄올(1 g) 3개의 활성분획을 수득하였다. 20%, 50% or 70% of ethyl acetate fraction was used as the eluent and Flex-Colum TM (3 cm × 25 cm) and Column chromatography was performed using Toyoperarl HW-40 (75 μm), ethyl acetate-20% methanol (9.41 g), ethyl acetate-50% methanol (5.74 g) and ethyl acetate-70% methanol (1 g). Three active fractions were obtained.
<< 비교예Comparative example 1> 옥수수수염 추출물의 제조 1> Preparation of Corn Beard Extract
옥수수수염 시료는 충북 제천시에 있는 농가에서 광평옥 품종의 옥수수수염을 채취하여 사용하였다. 옥수수수염 5 ㎏ 을 80% 메탄올(MeOH) 20 ℓ를 첨가하여 믹서기로 마쇄한 후 상온에서 3일간 침지시켜 얻은 추출물을 50℃에서 감압 농축하여 194 g의 옥수수수염 메탄올 추출물을 수득하였다.Corn beard samples were collected from a farm of Kwangpyeongok varieties from farms in Jecheon, Chungbuk. 5 kg of corn beard was added to 20 L of 80% methanol (MeOH), and then pulverized with a blender. The extract obtained by immersion at room temperature for 3 days was concentrated under reduced pressure at 50 ° C. to obtain 194 g of corn beard methanol extract.
<< 실험예Experimental Example 1> 1> 센티페드그라스Sentipedgrass 추출물 또는 이의 Extract or its 분획물로부터From fractions 분리한 활성분획에 존재하는 유용한 2차 Useful secondary present in isolated active fraction 대사산물의Metabolite 분석 analysis
애질런트 고성능액체크로마토그래피(Agilent high performance liquid chromatography, HPLC)(Agilent Technological, Palo Alto, CA, 미국)를 사용하여 센티페드그라스 메탄올 추출물, 상기 추출물로부터 분리한 에틸아세테이트-20%메탄올, 에틸아세테이트-50%메탄올 및 에틸아세테이트-70%메탄올 활성분획의 유용한 2차 대사산물을 분석하였다. 컬럼은 Beckman Coulter ULTRASPHERE(5 ㎛, 4.6 ㎜×25 ㎝)을 사용하였고, 컬럼의 온도는 40℃로 조절하였다. 0.1% 트리플루오로아세트산(trifluoroacetic acid)을 포함 한 용액(A)과 0.1% 트리플루오로아세트산(trifluoroacetic acid)을 포함한 50% 아세토나이트릴(acetonitrile) 용액(B)을 이동상으로 하여 HPLC를 수행하였다. 하기 [표 1]에 나타낸 이동상 조건에 따라, 50분간 1 ㎖/min 유속으로 유지하였다.Centipedgrass methanol extract using Agilent high performance liquid chromatography (Agilent Technological, Palo Alto, Calif., USA), ethyl acetate-20% methanol, ethyl acetate-50 isolated from the extract Useful secondary metabolites of% methanol and ethyl acetate-70% methanol active fractions were analyzed. The column used Beckman Coulter ULTRASPHERE (5 μm, 4.6 mm × 25 cm) and the temperature of the column was adjusted to 40 ° C. HPLC was carried out using a mobile phase containing a solution containing 0.1% trifluoroacetic acid (A) and a 50% acetonitrile solution (B) containing 0.1% trifluoroacetic acid as a mobile phase. . According to the mobile phase conditions shown in Table 1 below, the flow rate was maintained at 1 ml / min for 50 minutes.
그 결과, 센티페드그라스 메탄올 추출물에는 유용한 2차 대사산물인 클로로겐산(chlorogenic acid), 루틴(퀘세틴-3-O-루티노사이드{rutin(Quercetin-3-O-rutinoside)}, 나린진(나린제닌-7-O-네오헤스페리도사이드){naringin(naringenin-7-O-neohesperidoside)}, 이소오리엔틴(isoorientin), 람노실이소오리엔틴(rhamnosylisoorientin), 이소로이폴린(아피제닌-7-O-루티노사이드){isorhoifolin(apigenin-7-O-rutinoside)}, 이소채프토사이드(아피제닌-6-C-아라비노실-8-C-글루코사이드{isoschaftoside(Apigenin-6-C-arabinosyl-8-C-glucoside)} 및 메이신(maysiin)이 존재하는 것으로 나타났다(도 2). As a result, the centifedgrass methanol extract contains useful secondary metabolites such as chlorogenic acid, rutin (Quercetin-3-O-rutinoside), and naringinin. Naringin (naringenin-7-O-neohesperidoside), isoorientin, rhamnosylisoorientin, iso-ipoline (apigenin-7-O) -Isotinifol {isorhoifolin (apigenin-7-O-rutinoside)}, isochaptoside (apigenin-6- C- arabinosyl-8-C-glucoside {isoschaftoside (Apigenin-6- C- arabinosyl-8) C- glucoside) and maysiin (FIG. 2).
또한, 센티페드그라스 에틸아세테이트-20%메탄올 활성분획에는 유용한 2차 대사산물인 이소오리엔틴(isoorientin), 람노실이소오리엔틴(rhamnosylisoorientin), 이소로이폴린(아피제닌-7-O-루티노사이드){isorhoifolin(apigenin-7-O-rutinoside)}, 이소채프토사이드(아피제닌-6-C-아라비노실-8-C-글루코사이드{isoschaftoside(Apigenin-6-C-arabinosyl-8-C-glucoside)} 및 메이신(maysiin)이 존재하는 것으로 나타났다(도 3). 센티페드그라스 에틸아세테이트-50%메탄올 활성분획에는 유용한 2차 대사산물인 이소오리엔틴(isoorientin), 람노실이소오리엔틴(rhamnosylisoorientin), 이소로이폴린(아피제닌-7-O-루티노사이드){isorhoifolin(apigenin-7-O-rutinoside)} 및 메이신(maysiin)이 존재하는 것으로 나타났다(도 4). 아울러 센티페드그라스 에틸아세테이트-70%메탄올 활성분획에는 유용한 2차 대사산물인 메이신(maysiin)이 존재하는 것으로 나타났다(도 5).Secondary metabolites such as isoorientin, rhamnosylisoorientin, and isoleuropoline (apigenin-7-O-rutinoside) are also useful for centrifuged glass ethyl acetate-20% methanol active fractions {isorhoifolin (apigenin-7-O-rutinoside)}, isochaptoside (apigenin-6- C- arabinosyl-8-C-glucoside {isoschaftoside (Apigenin-6- C- arabinosyl-8- C -glucoside ) And maysiin (Fig. 3) .The active metabolite isoorientin, rhamnosylisoorientin, useful for centifedgrass ethyl acetate-50% methanol active fractions. ), Isoleuropoline (apigenin-7-O-rutinoside) {isorhoifolin (apigenin-7-O-rutinoside)} and maysiin were shown to exist (FIG. 4). The acetate-70% methanol active fraction contains maysiin, a useful secondary metabolite. It appeared to exist (FIG. 5).
(구배 조건)Extraction mode
(Gradient conditions)
<< 실험예Experimental Example 2> 엘라스타아제( 2> elastase ( elastaseelastase ) 저해 활성을 통한 주름개선 효과 측정) Measurement of wrinkle improvement effect through inhibitory activity
<2-1> <2-1> 센티페드그라스Sentipedgrass 추출물의 농도에 따른 주름개선 효과 측정 Wrinkle improvement effect according to the concentration of extract
돼지의 췌장 엘라스타아제(elastase) 저해 활성 측정은 기질로서 N-석시닐-(L-알라닌)3-p-니트로아닐리드{N-succinyl-(L-Ala)3-p-nitroanilide}를 사용하여 37℃에서 30분간 p-니트로아닐리드(p-nitroanilide)의 생성량을 405 ㎚에서 측정하였다. 상기 <실시예 1>에서 수득한 센티페드그라스 추출물 또는 상기 <비교예 1>에서 수득한 옥수수수염 추출물 100 ㎕에 50 mM 트리스-염산 완충용액{Tri-HCl buffer(pH 8.6)}에 녹인 엘라스타아제(2.5 unit) 용액 100 ㎕를 가한 후에 100 ㎕의 0.4 M 트리스-염산{Tri- HCl(pH 8.6)}을 첨가하였다. 첨가 후, 200 ㎕의 기질용액[50 mM 트리스-염산 완충용액{Tris-HCl buffer(pH 8.6)}에 녹여져 있는 기질 N-석시닐-(L-알라닌)3-p-니트로아닐리드{N-succinyl-(L-Ala)3-p-nitroanilide(0.5 ㎎/㎖)}를 첨가하여 총 부피를 500 ㎕로 맞추어 추출물의 최종농도를 20, 200, 2000 또는 4000 ㎍/㎖로 하여, 37°C에서 20분간 반응시킨 후 405 ㎚에서 측정하였다. 양성대조군으로 100 ㎍/㎖의 어솔릭산(ursolic acid)을 사용하였으며, 음성대조군으로는 시료를 녹인 용매를 사용하여 측정하였다. 엘라스타아제 저해 활성은 추출물의 첨가군과 무첨가군의 흡광도 감소율로 나타내며, 하기 [수학식 1]에 따라 계산하였다.Measurement of pancreatic elastase inhibitory activity in pigs was carried out using N -succinyl- (L-alanine) 3 - p -nitroanilide { N -succinyl- (L-Ala) 3 - p -nitroanilide} as substrate. The production amount of p -nitroanilide for 30 minutes at 37 ° C was measured at 405 nm. Elasta dissolved in 50 mM Tris-HCl buffer solution (Tri-HCl buffer (pH 8.6)} in 100 μl of the centipedes grass extract obtained in Example 1 or the corn beard extract obtained in Comparative Example 1. 100 [mu] l of a 2.5 unit solution was added followed by 100 [mu] l of 0.4 M Tris-HCl (Tri-HCl, pH 8.6). After addition, substrate N -succinyl- (L-alanine) 3 - p -nitroanilide { N -dissolved in 200 μl of substrate solution [50 mM Tris-HCl buffer (pH 8.6)}. succinyl- (L-Ala) 3 - p -nitroanilide (0.5 mg / ml)} to a total volume of 500 μl and the final concentration of the extract to 20, 200, 2000 or 4000 μg / ml, 37 ° C. After reacting for 20 minutes at, it was measured at 405 nm. 100 ㎍ / ㎖ assolic acid (ursolic acid) was used as a positive control, the negative control was measured using a solvent dissolved sample. Elastase inhibitory activity is expressed as the absorbance decrease rate of the addition group and no addition group of the extract, it was calculated according to the following [Equation 1].
그 결과, 센티페드그라스 메탄올 추출물의 주름개선 효과는 20, 200, 2000 및 4000 ㎍/㎖의 농도에서 각각 약 24, 50, 91 및 93%의 엘라스타아제 저해 활성을 나타낸 반면에 옥수수수염 메탄올 추출물은 상기와 같은 20, 200, 2000 및 4000 ㎍/㎖의 농도에서 각각 약 8, 17, 59 및 75%의 엘라스타아제 저해 활성을 나타냈다(표 2 및 도 6). 따라서 센티페드그라스 추출물이 옥수수수염 추출물보다 피부 주름개선 효과가 현저하게 높은 것으로 확인되었다.As a result, the antiwrinkle effect of the centipedes glass methanol extract showed about 24, 50, 91 and 93% of elastase inhibitory activity at concentrations of 20, 200, 2000 and 4000 ㎍ / ml, respectively. Showed elastase inhibitory activity of about 8, 17, 59 and 75% at concentrations of 20, 200, 2000 and 4000 μg / ml, respectively (Table 2 and FIG. 6). Therefore, it was confirmed that the centipedes grass extract has a significantly higher skin wrinkle improvement effect than the corn beard extract.
티
페
드
그
라
스
sen
tea
Fe
De
That
la
S
Methanol extract
Ethanol extract
Water extract
수염corn
<2-2> <2-2> 센티페드그라스Sentipedgrass 추출물, 이의 Extract, its 분획물Fraction 또는 상기 Or above 분획물로부터From fractions 분리한 활성분획의 항산화 활성 측정 Determination of Antioxidant Activity from Isolated Active Fractions
상기 실험예 <2-1>의 방법에 따라 4000 ㎍/㎖의 센티페드그라스 추출물, 이의 분획물 또는 상기 분획물로부터 분리한 활성분획의 엘라스타아제 저해 활성을 측정하였다.In accordance with the method of Experimental Example <2-1>, the elastase inhibitory activity of the 4000 μg / ㎖ Centifed Grass extract, fractions thereof, or the active fractions isolated from the fractions was measured.
그 결과, 센티페드그라스 메탄올, 에탄올 또는 물 추출물은 각각 약 98, 96 및 97%의 엘라스타아제 저해 활성을 나타냈고, 에틸아세테이트 분획물로부터 분리한 활성분획은 약 92%의 엘라스타아제 저해 활성을 나타냈다(표 3 및 도 7). As a result, centifedgrass methanol, ethanol or water extract showed about 98, 96 and 97% elastase inhibitory activity, and the active fraction isolated from the ethyl acetate fraction showed about 92% elastase inhibitory activity. (Table 3 and FIG. 7).
<< 제조예Manufacturing example 1> 1> 센티페드그라스Sentipedgrass 추출물, 이의 Extract, its 분획물Fraction 또는 상기 Or above 분획물로부터From fractions 분리한 활성분획을 유효성분으로 함유하는 피부 주름개선용 For wrinkle improvement of skin containing separated active fraction as active ingredient 화장료의Cosmetic 제조 Produce
<1-1> 유연 화장수의 제조<1-1> preparation of flexible lotion
상기 실시예 <1-2>의 센티페드그라스 에탄올 추출물을 유효성분으로 함유하는 유연 화정수는 하기 [표 4]와 같이 제조하였다.The flexible purified water containing the centipede glass ethanol extract of Example <1-2> as an active ingredient was prepared as shown in [Table 4].
<1-2> 영양 크림의 제조<1-2> Preparation of nourishing cream
상기 실시예 <1-2>의 센티페드그라스 에탄올 추출물을 유효성분으로 함유한 영양크은 하기 [표 5]의 조성과 같이 제조하였다. Nutrients containing the centipede glass ethanol extract of Example <1-2> as an active ingredient was prepared as shown in the composition of the following [Table 5].
<< 제조예Manufacturing example 2> 2> 센티페드그라스Sentipedgrass 추출물, 이의 Extract, its 분획물Fraction 또는 상기 Or above 분획물로부터From fractions 분리한 활성분획을 유효성분으로 함유하는 피부 주름개선용 약제의 제조 Preparation of medicament for skin wrinkles containing separated active fraction as an active ingredient
<2-1> 시럽제의 제조<2-1> Preparation of Syrup
상기 <실시예 2>의 센티페드그라스 에틸아세테이트-20%메탄올 활성분획을 유효성분으로 함유하는 시럽제는 하기 [표 6]의 조성과 같이 제조하였다.The syrup containing the centipede glass ethyl acetate-20% methanol active fraction of <Example 2> as an active ingredient was prepared as shown in the following [Table 6].
<2-2> 정제의 제조<2-2> Preparation of Tablet
상기 <실시예 2>의 센티페드그라스 에틸아세테이트-20%메탄올 활성분획을 유효성분으로 함유하는 정제는 하기 [표 7]의 조성과 같이 제조하였다.The tablet containing the centipede glass ethyl acetate-20% methanol active fraction of <Example 2> as an active ingredient was prepared as shown in the following [Table 7].
상기 <실시예 2>의 에틸아세테이트-20%메탄올 활성분획 250 중량부, 락토오스 175.9 중량부, 감자전분 180 중량부 및 콜로이드성 규산 32 중량부와 혼합하였다. 상기 혼합물에 10% 젤라틴 용액을 첨가시킨 후, 분쇄하여 14 매쉬체를 통과시켰다. 이것을 건조하고 여기에 감자전분 160 중량부, 활석 50 중량부 및 스테아린산 마그네슘 5 중량부를 첨가하여 얻은 혼합물을 정제로 제조하였다.250 parts by weight of the ethyl acetate-20% methanol active fraction of <Example 2>, 175.9 parts by weight of lactose, 180 parts by weight of potato starch, and 32 parts by weight of colloidal silicic acid were mixed. 10% gelatin solution was added to the mixture, which was then ground and passed through a 14 mesh sieve. This was dried and the mixture obtained by adding 160 parts by weight of potato starch, 50 parts by weight of talc and 5 parts by weight of magnesium stearate was prepared as a tablet.
<< 제조예Manufacturing example 3> 3> 센티페드그라스Sentipedgrass 추출물, 이의 Extract, its 분획물Fraction 또는 상기 Or above 분획물로부터From fractions 분리한 활성분획을 유효성분으로 함유하는 피부 주름개선용 건강식품의 제조 Preparation of health food for skin wrinkle improvement containing separated active fraction as active ingredient
상기 실시예 <1-3>의 센티페드그라스 물 추출물을 유효성분으로 함유하는 식품들을 다음과 같이 제조하였다.Foods containing the centipede glass water extract of Example <1-3> as an active ingredient were prepared as follows.
<3-1> 밀가루 식품의 제조<3-1> Production of flour food
상기 실시예 <1-3>의 추출물 0.5~5.0 중량부를 밀가루에 첨가하고, 이 혼합물을 이용하여 빵, 케이크, 쿠키, 크래커 및 면류를 제조하였다.0.5 to 5.0 parts by weight of the extract of Example <1-3> was added to the flour, and bread, cake, cookies, crackers, and noodles were prepared using the mixture.
<3-2> <3-2> 스프soup 및 육즙( And juicy ( graviesgravies )의 제조Manufacturing
상기 실시예 <1-3>의 추출물 0.1~5.0 중량부를 스프 및 육즙에 첨가하여 건강 증진용 육가공 제품, 면류의 수프 및 육즙을 제조하였다.0.1 to 5.0 parts by weight of the extract of Example <1-3> was added to soups and broths to prepare meat products for health promotion, soups and noodles for noodles.
<3-3> 그라운드 <3-3> Ground 비프(ground beef)의Beef 제조 Produce
상기 실시예 <1-3>의 추출물 10 중량부를 그라운드 비프에 첨가하여 건강 증진용 그라운드 비프를 제조하였다.10 parts by weight of the extract of Example <1-3> was added to the ground beef to prepare a ground beef for health promotion.
<3-4> 유제품(<3-4> Dairy products ( dairydairy productsproducts )의 제조Manufacturing
상기 실시예 <1-3>의 추출물 5~10 중량부를 우유에 첨가하고, 상기 우유를 이용하여 버터 및 아이스크림과 같은 다양한 유제품을 제조하였다.5-10 parts by weight of the extract of Example <1-3> was added to milk, and various dairy products such as butter and ice cream were prepared using the milk.
<3-5> <3-5> 선식의Solar 제조 Produce
현미, 보리, 찹쌀, 율무를 공지의 방법으로 알파화시켜 건조시킨 것을 배전한 후 분쇄기로 입도 60 메쉬의 분말로 제조하였다.Brown rice, barley, glutinous rice, and yulmu were dried by a known method and dried, and the mixture was granulated to a powder having a particle size of 60 mesh.
검정콩, 검정깨, 들깨도 공지의 방법으로 쪄서 건조시킨 것을 배전한 후 분쇄기로 입도 60 메쉬의 분말로 제조하였다.Black soybeans, black sesame seeds, and perilla seeds were steamed and dried by a conventional method, and then they were prepared into powder having a particle size of 60 mesh by a pulverizer.
상기 실시예 <1-3>의 추출물을 진공 농축기에서 감압농축하고, 분무, 열풍건조기로 건조하여 얻은 건조물을 분쇄기로 입도 60 메쉬로 분쇄하여 건조분말을 얻었다.The extract of Example <1-3> was concentrated under reduced pressure in a vacuum concentrator, and the dried product obtained by drying with a spray and a hot air dryer was pulverized with a particle size of 60 mesh to obtain a dry powder.
상기에서 제조한 곡물류, 종실류 및 실시예 <1-3>의 추출물을 다음의 비율로 배합하여 제조하였다.The grains, seeds, and extracts of Example <1-3> prepared above were prepared by combining the following ratios.
곡물류(현미 30 중량부, 율무 15 중량부, 보리 20 중량부),Cereals (30 parts by weight brown rice, 15 parts by weight brittle, 20 parts by weight of barley),
종실류(들깨 7 중량부, 검정콩 8 중량부, 검정깨 7 중량부),Seeds (7 parts by weight of perilla, 8 parts by weight of black beans, 7 parts by weight of black sesame seeds)
실시예 <1-3>의 추출물(3 중량부),Extract (3 parts by weight) of Example <1-3>,
영지(0.5 중량부),(0.5 part by weight),
지황(0.5 중량부)Foxglove (0.5 part by weight)
<< 제조예Manufacturing example 4> 4> 센티페드그라스Sentipedgrass 추출물, 이의 Extract, its 분획물Fraction 또는 상기 Or above 분획물로부터From fractions 분리한 활성분획을 유효성분으로 함유하는 피부 주름개선용 음료의 제조 Preparation of a beverage for skin wrinkles containing the separated active fraction as an active ingredient
<4-1> <4-1> 건강음료의Health drink 제조 Produce
액상과당(0.5%), 올리고당(2%), 설탕(2%), 식염(0.5%), 물(75%)과 같은 부재료와 본 발명의 실시예 <1-3>의 추출물 5 g을 균질하게 배합하여 순간 살균을 한 후 이를 유리병, 패트병 등 소포장 용기에 포장하여 제조하였다.Homogeneous components such as liquid fructose (0.5%), oligosaccharides (2%), sugar (2%), salt (0.5%), water (75%) and 5 g of the extract of Example 1-3 of the present invention are homogeneous. After sterilization and instant sterilization, it was prepared by packaging in small packaging containers such as glass bottles and plastic bottles.
<4-2> 야채 주스의 제조<4-2> Production of vegetable juice
상기 실시예 <1-3>의 추출물 5 g을 토마토 또는 당근 주스 1,000 ㎖에 가하여 야채 주스를 제조하였다.5 g of the extract of Example <1-3> was added to 1,000 ml of tomato or carrot juice to prepare vegetable juice.
<4-3> 과일 주스의 제조<4-3> Preparation of fruit juice
상기 실시예 <1-3>의 추출물 1 g을 사과 또는 포도 주스 1,000 ㎖ 에 가하여 과일 주스를 제조하였다.1 g of the extract of Example <1-3> was added to 1,000 ml of apple or grape juice to prepare a fruit juice.
상기와 같이, 본 발명의 센티페드그라스 추출물, 이의 분획물 또는 상기 분획물로부터 분리한 활성분획은 엘라스타아제 저해 효과가 뛰어나 주름개선에 탁월한 효과가 있으므로 피부 주름개선을 위한 화장품, 피부 외용제, 약제 또는 건강식품의 개발 및 제품 생산에 유용하게 이용될 수 있다. As described above, the centifed glass extract of the present invention, its fractions or the active fractions separated from the fractions have excellent elastase inhibitory effect and have an excellent effect on wrinkle improvement, so that cosmetics, external preparations for skin wrinkles, drugs or health It can be usefully used for food development and product production.
도 1은 센티페드그라스의 추출물, 이의 분획물 및 상기 분획물로부터 분리한 활성분획을 제조하는 과정을 나타낸 그림이다.1 is a diagram illustrating a process for preparing an extract of centipedegrass, fractions thereof, and active fractions separated from the fractions.
도 2는 센티페드그라스 메탄올 추출물에 존재하는 2차 대사산물을 동정한 고성능액체크로마토그래피를 나타낸 그림이다.2 is a diagram showing high performance liquid chromatography identifying secondary metabolites present in centipedegrass methanol extract.
도 3은 센티페드그라스 에틸아세테이트-20%메탄올 활성분획에 존재하는 2차 대사산물을 동정한 고성능액체크로마토그래피를 나타낸 그림이다. Figure 3 is a diagram showing high performance liquid chromatography identifying secondary metabolites present in centifed glass ethyl acetate-20% methanol active fractions.
도 4는 센티페드그라스 에틸아세테이트-50%메탄올 활성분획에 존재하는 2차 대사산물을 동정한 고성능액체크로마토그래피를 나타낸 그림이다. FIG. 4 is a diagram showing high performance liquid chromatography identifying secondary metabolites present in centifed glass ethyl acetate-50% methanol active fraction.
도 5는 센티페드그라스 에틸아세테이트-70%메탄올 활성분획에 존재하는 2차 대사산물을 동정한 고성능액체크로마토그래피를 나타낸 그림이다.FIG. 5 is a diagram showing high performance liquid chromatography identifying secondary metabolites present in centifed glass ethyl acetate-70% methanol active fraction.
도 6은 센티페드그라스 메탄올 추출물 또는 옥수수수염 메탄올 추출물의 농도에 따른 엘라스타아제 저해율을 나타낸 그래프이다.Figure 6 is a graph showing the inhibition rate of elastase according to the concentration of centipede glass methanol extract or corn beard methanol extract.
도 7은 센티페드그라스 메탄올 추출물, 이의 분획물로부터 분리한 활성분획(에틸아세테트-20%메탄올, -50%메탄올 및 -70%메탄올)의 엘라스타아제 저해율을 나타낸 그래프이다. 7 is a graph showing the elastase inhibition rate of the active fraction (ethylacetate-20% methanol, -50% methanol and -70% methanol) separated from the centipedes glass methanol extract and fractions thereof.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090111510A KR101125225B1 (en) | 2009-11-18 | 2009-11-18 | A composition for skin wrinkle improvement comprising extracts or fractions of Eremochloa ophiuroides as an active ingredient |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090111510A KR101125225B1 (en) | 2009-11-18 | 2009-11-18 | A composition for skin wrinkle improvement comprising extracts or fractions of Eremochloa ophiuroides as an active ingredient |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20110054747A KR20110054747A (en) | 2011-05-25 |
KR101125225B1 true KR101125225B1 (en) | 2012-03-21 |
Family
ID=44363896
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020090111510A Active KR101125225B1 (en) | 2009-11-18 | 2009-11-18 | A composition for skin wrinkle improvement comprising extracts or fractions of Eremochloa ophiuroides as an active ingredient |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101125225B1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101398549B1 (en) * | 2012-07-24 | 2014-05-27 | 한국원자력연구원 | A composition for skin disease improvement comprising extracts or fractions of Eremochloa ophiuroides as an active ingredient |
EP3042663B1 (en) * | 2012-09-17 | 2018-09-26 | Korea Atomic Energy Research Institute | Composition comprising centipede grass extracts or fractions thereof as active ingredients |
US20190336560A1 (en) | 2016-12-12 | 2019-11-07 | Korea Atomic Energy Research Institute | Pharmaceutical composition for the prevention or treatment of alopecia comprising eremochloa ophiuroides extract or fractions thereof as an active ingredient |
KR102531591B1 (en) * | 2021-01-07 | 2023-05-15 | 한국원자력연구원 | Composition for UV protection comprising extract of Eremochloa ophiuroides and cosmetic composition comprising the same |
KR102648047B1 (en) * | 2022-02-21 | 2024-03-18 | 한국원자력연구원 | Method for preparing ferment extract of Eremochloa ophiuroides, ferment extract of Eremochloa ophiuroides and complex functional cosmetic composition comprising the same |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040065583A (en) * | 2003-01-14 | 2004-07-23 | 주식회사 엘지생활건강 | Composition having inhibitory effect on formation of skin wrinkle |
KR100771397B1 (en) | 2006-06-08 | 2007-10-30 | 인제대학교 산학협력단 | Cosmetic composition containing dandelion extract having antioxidant and anti-inflammatory effects or luteolin isolated therefrom |
KR20080036302A (en) * | 2006-10-23 | 2008-04-28 | 재단법인 제주하이테크산업진흥원 | Preparation method of tea extract and cosmetic composition for preventing skin aging and anti-wrinkle containing tea extract as an active ingredient |
KR20110040375A (en) * | 2009-10-14 | 2011-04-20 | 한국원자력연구원 | Method of removing pigment from centipedegrass extract using radiation |
-
2009
- 2009-11-18 KR KR1020090111510A patent/KR101125225B1/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040065583A (en) * | 2003-01-14 | 2004-07-23 | 주식회사 엘지생활건강 | Composition having inhibitory effect on formation of skin wrinkle |
KR100771397B1 (en) | 2006-06-08 | 2007-10-30 | 인제대학교 산학협력단 | Cosmetic composition containing dandelion extract having antioxidant and anti-inflammatory effects or luteolin isolated therefrom |
KR20080036302A (en) * | 2006-10-23 | 2008-04-28 | 재단법인 제주하이테크산업진흥원 | Preparation method of tea extract and cosmetic composition for preventing skin aging and anti-wrinkle containing tea extract as an active ingredient |
KR20110040375A (en) * | 2009-10-14 | 2011-04-20 | 한국원자력연구원 | Method of removing pigment from centipedegrass extract using radiation |
Also Published As
Publication number | Publication date |
---|---|
KR20110054747A (en) | 2011-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102113193B1 (en) | Composition for improving skin conditions comprising artemisiae annuae herba, centella asiatica and green tea extract or fraction thereof and method for improving skin conditions using the same | |
KR101292837B1 (en) | Composition for skin wrinkle improvement comprising extracts of Junglans mandshurica MAXIM as an active ingredient | |
KR102070789B1 (en) | Composition for ameliorating or treating acne comprising Salvia plebeia extract and its fraction as effective component | |
KR101125225B1 (en) | A composition for skin wrinkle improvement comprising extracts or fractions of Eremochloa ophiuroides as an active ingredient | |
KR101611853B1 (en) | Aster glehni fractions or compounds isolated therefrom having anti-inflammatory activity | |
KR101295368B1 (en) | Composition for skin wrinkle improvement comprising extracts of honeybush extract or its fermentation solution as an active ingredient | |
KR101125224B1 (en) | A composition for skin anti-aging comprising extracts or fractions of Eremochloa ophiuroides as an active ingredient | |
KR101197531B1 (en) | A composition for skin whitening comprising extracts or fractions of Eremochloa ophiuroides as an active ingredient | |
WO2011043212A1 (en) | Ceramide production enhancer and moisturizing agent | |
KR101125223B1 (en) | Method for removing the pigment of Centipede grass extract using irradiation | |
KR101188682B1 (en) | Composition for skin whitening comprising extracts of Veronica longiofolia L. | |
KR101046688B1 (en) | Aspergillus terius extract, novel butyrolactone derivative or pharmaceutically acceptable salt thereof, preparation method thereof and antioxidant composition containing the same as an active ingredient | |
KR102741204B1 (en) | Composition for improving skin | |
KR102577528B1 (en) | Composition for improving skin | |
KR102012170B1 (en) | Composition comprising extracts of banana, cherry, and walnut for anti-skin aging | |
KR20180104960A (en) | Composition comprising extracts of banana, cherry, and walnut for anti-skin aging | |
KR20100042086A (en) | Composition for whitening containing extract of cortex cinnamomi cassiae | |
KR101661423B1 (en) | anti-oxidant and anti-inflammation composition extracted from Isodon excisus, and its extracting method | |
KR102741071B1 (en) | Composition for improving skin | |
KR102741072B1 (en) | Composition for improving skin | |
KR101797843B1 (en) | A composition having anti-inflammation or anti-bacterial activity comprising Acanthopanax koreanum Nakai stem extracts, fractions thereof or compounds isolated therefrom as an active ingredient | |
KR102445679B1 (en) | Antioxidant composition comprising silkworm pupa extract and red ginseng extract | |
KR101464406B1 (en) | Composition containing extracts or fractions of tilia taquetii schneid as an active ingredient and its use | |
KR101425047B1 (en) | Composition for antioxidant comprising extract or fractions of Rhododendron album Blume as an active ingredient | |
KR102590758B1 (en) | Antioxidant or anti-inflammatory composition comprising extract of bilberry containing anthocyanidin components |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20091118 |
|
PA0201 | Request for examination | ||
PG1501 | Laying open of application | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20110921 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20120229 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20120302 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20120305 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20141230 Start annual number: 4 End annual number: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20160129 Start annual number: 5 End annual number: 5 |
|
FPAY | Annual fee payment |
Payment date: 20170111 Year of fee payment: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20170111 Start annual number: 6 End annual number: 6 |
|
FPAY | Annual fee payment |
Payment date: 20171207 Year of fee payment: 7 |
|
PR1001 | Payment of annual fee |
Payment date: 20171207 Start annual number: 7 End annual number: 7 |
|
FPAY | Annual fee payment |
Payment date: 20190104 Year of fee payment: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20190104 Start annual number: 8 End annual number: 8 |
|
FPAY | Annual fee payment |
Payment date: 20200102 Year of fee payment: 9 |
|
PR1001 | Payment of annual fee |
Payment date: 20200102 Start annual number: 9 End annual number: 9 |
|
PR1001 | Payment of annual fee |
Payment date: 20201223 Start annual number: 10 End annual number: 10 |
|
PR1001 | Payment of annual fee |
Payment date: 20220103 Start annual number: 11 End annual number: 11 |
|
PR1001 | Payment of annual fee |
Payment date: 20241223 Start annual number: 14 End annual number: 14 |